Bingham Osborn & Scarborough’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-12,809
| Closed | -$2.07M | – | 81 |
|
|
2021
Q3 | $2.07M | Buy |
12,809
+391
| +3% | +$66.7K | 0.15% | 37 |
|
|
2021
Q2 | $2.05M | Buy |
12,418
+838
| +7% | +$139K | 0.14% | 36 |
|
|
2021
Q1 | $1.9M | Buy |
11,580
+704
| +6% | +$114K | 0.14% | 34 |
|
|
2020
Q4 | $1.71M | Sell |
10,876
-548
| -5% | -$80.9K | 0.14% | 33 |
|
|
2020
Q3 | $1.7M | Buy |
11,424
+403
| +4% | +$59.6K | 0.13% | 44 |
|
|
2020
Q2 | $1.55M | Sell |
11,021
-49
| -0.4% | -$7.14K | 0.12% | 46 |
|
|
2020
Q1 | $1.45M | Buy |
11,070
+930
| +9% | +$132K | 0.14% | 43 |
|
|
2019
Q4 | $1.48M | Buy |
10,140
+404
| +4% | +$54.8K | 0.12% | 46 |
|
|
2019
Q3 | $1.26M | Sell |
9,736
-32
| -0.3% | -$4.22K | 0.11% | 51 |
|
|
2019
Q2 | $1.36M | Sell |
9,768
-565
| -5% | -$78.2K | 0.12% | 44 |
|
|
2019
Q1 | $1.44M | Sell |
10,333
-347
| -3% | -$46.5K | 0.13% | 39 |
|
|
2018
Q4 | $1.38M | Sell |
10,680
-290
| -3% | -$40.5K | 0.14% | 39 |
|
|
2018
Q3 | $1.52M | Buy |
10,970
+2,319
| +27% | +$308K | 0.13% | 43 |
|
|
2018
Q2 | $1.05M | Buy |
8,651
+217
| +3% | +$27.1K | 0.1% | 47 |
|
|
2018
Q1 | $1.08M | Sell |
8,434
-229
| -3% | -$31K | 0.1% | 50 |
|
|
2017
Q4 | $1.21M | Buy |
8,663
+133
| +2% | +$18.5K | 0.11% | 38 |
|
|
2017
Q3 | $1.11M | Buy |
8,530
+866
| +11% | +$115K | 0.1% | 38 |
|
|
2017
Q2 | $1.01M | Sell |
7,664
-9
| -0.1% | -$1.15K | 0.1% | 43 |
|
|
2017
Q1 | $956K | Buy |
7,673
+388
| +5% | +$46.4K | 0.09% | 40 |
|
|
2016
Q4 | $839K | Sell |
7,285
-671
| -8% | -$77.5K | 0.09% | 41 |
|
|
2016
Q3 | $940K | Buy |
7,956
+1,042
| +15% | +$126K | 0.1% | 41 |
|
|
2016
Q2 | $839K | Buy |
6,914
+97
| +1% | +$11K | 0.1% | 46 |
|
|
2016
Q1 | $738K | Sell |
6,817
-220
| -3% | -$22.8K | 0.09% | 51 |
|
|
2015
Q4 | $723K | Sell |
7,037
-476
| -6% | -$47.9K | 0.09% | 49 |
|
|
2015
Q3 | $701K | Sell |
7,513
-849
| -10% | -$82.1K | 0.09% | 51 |
|
|
2015
Q2 | $815K | Buy |
8,362
+508
| +6% | +$50.9K | 0.1% | 46 |
|
|
2015
Q1 | $790K | Sell |
7,854
-375
| -5% | -$38.1K | 0.09% | 50 |
|
|
2014
Q4 | $860K | Sell |
8,229
-58
| -0.7% | -$6.11K | 0.1% | 46 |
|
|
2014
Q3 | $883K | Buy |
8,287
+706
| +9% | +$73.2K | 0.11% | 43 |
|
|
2014
Q2 | $793K | Sell |
7,581
-1,260
| -14% | -$127K | 0.11% | 42 |
|
|
2014
Q1 | $868K | Buy |
8,841
+116
| +1% | +$10.8K | 0.12% | 37 |
|
|
2013
Q4 | $799K | Buy |
8,725
+2,784
| +47% | +$257K | 0.12% | 40 |
|
|
2013
Q3 | $515K | Buy |
5,941
+2,040
| +52% | +$183K | 0.08% | 49 |
|
|
2013
Q2 | $335K | Buy |
+3,901
| New | +$331K | 0.06% | 57 |
|
Other funds holding JNJ
Bingham Osborn & Scarborough's JNJ Position: Q4 2021 in Review
Bingham Osborn & Scarborough sold out of Johnson & Johnson (JNJ) in Q4 2021, closing a stake of 12,809 shares — an estimated $2.07M sold.
Bingham Osborn & Scarborough first reported a position in JNJ in Q2 2013 and held it in 34 quarters. The position peaked at $2.07M in Q3 2021. 3,644 funds tracked by Wall St. Rank hold JNJ as of Q4 2021.
- Bingham Osborn & Scarborough reported no remaining Johnson & Johnson position as of Q4 2021 after selling out during the quarter.
- Bingham Osborn & Scarborough sold 12,809 Johnson & Johnson shares in Q4 2021, an estimated $2.07M.
- Bingham Osborn & Scarborough first reported a position in Johnson & Johnson in Q2 2013 and held it in 34 quarters.
- Bingham Osborn & Scarborough's Johnson & Johnson position peaked at $2.07M in Q3 2021.
- 3,644 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2021.
Based on Bingham Osborn & Scarborough's 13F filing for Q4 2021.